Aptose Biosciences Inc. (TSX: APS)
Canada
· Delayed Price · Currency is CAD 0.340
-0.025 (-6.85%)
Dec 27, 2024, 3:59 PM EST
Aptose Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 7.96 | 9.25 | 36.97 | 39.11 | 117.39 | 79.84 | Upgrade
|
| Short-Term Investments | - | - | 9.99 | 40.01 | 5 | 17.76 | Upgrade
|
| Cash & Short-Term Investments | 7.96 | 9.25 | 46.96 | 79.13 | 122.39 | 97.6 | Upgrade
|
| Cash Growth | -55.06% | -80.30% | -40.65% | -35.35% | 25.40% | 520.12% | Upgrade
|
| Prepaid Expenses | 0.91 | 2.04 | 2.3 | 2.48 | 2.55 | 1.03 | Upgrade
|
| Other Current Assets | 1.36 | 0.6 | 0.26 | 0.13 | 0.13 | 0.14 | Upgrade
|
| Total Current Assets | 10.24 | 11.89 | 49.52 | 81.74 | 125.08 | 98.77 | Upgrade
|
| Property, Plant & Equipment | 0.69 | 1.1 | 1.51 | 0.79 | 1.14 | 1.62 | Upgrade
|
| Other Intangible Assets | - | - | - | - | 0.05 | 0.09 | Upgrade
|
| Total Assets | 10.93 | 12.99 | 51.03 | 82.53 | 126.26 | 100.48 | Upgrade
|
| Accounts Payable | 1.83 | 6.05 | 6.33 | 1.7 | 2.17 | 1.96 | Upgrade
|
| Accrued Expenses | 7.51 | 8.83 | 5.66 | 6.02 | 4.1 | 3.06 | Upgrade
|
| Current Portion of Leases | 0.42 | 0.39 | 0.3 | 0.46 | 0.54 | 0.52 | Upgrade
|
| Total Current Liabilities | 9.76 | 15.27 | 12.28 | 8.17 | 6.81 | 5.54 | Upgrade
|
| Long-Term Debt | 10 | - | - | - | - | - | Upgrade
|
| Long-Term Leases | 0.31 | 0.62 | 1 | 0.12 | 0.54 | 1.01 | Upgrade
|
| Total Liabilities | 20.06 | 15.89 | 13.29 | 8.29 | 7.35 | 6.55 | Upgrade
|
| Common Stock | 452.3 | 444.81 | 437.52 | 437.39 | 429.52 | 365.49 | Upgrade
|
| Additional Paid-In Capital | 82.26 | 72.15 | 68.87 | 63.67 | 50.86 | 34.65 | Upgrade
|
| Retained Earnings | -539.38 | -515.54 | -464.33 | -422.51 | -357.15 | -301.92 | Upgrade
|
| Comprehensive Income & Other | -4.32 | -4.32 | -4.32 | -4.32 | -4.32 | -4.3 | Upgrade
|
| Shareholders' Equity | -9.13 | -2.9 | 37.74 | 74.24 | 118.92 | 93.93 | Upgrade
|
| Total Liabilities & Equity | 10.93 | 12.99 | 51.03 | 82.53 | 126.26 | 100.48 | Upgrade
|
| Total Debt | 10.72 | 1.02 | 1.3 | 0.57 | 1.07 | 1.53 | Upgrade
|
| Net Cash (Debt) | -2.76 | 8.24 | 45.66 | 78.55 | 121.32 | 96.07 | Upgrade
|
| Net Cash Growth | - | -81.96% | -41.88% | -35.25% | 26.28% | 510.38% | Upgrade
|
| Net Cash Per Share | -0.20 | 1.22 | 7.42 | 13.23 | 22.24 | 28.73 | Upgrade
|
| Filing Date Shares Outstanding | 19.52 | 15.72 | 6.2 | 6.15 | 5.93 | 5.08 | Upgrade
|
| Total Common Shares Outstanding | 19.52 | 7.94 | 6.16 | 6.15 | 5.93 | 5.07 | Upgrade
|
| Working Capital | 0.48 | -3.38 | 37.24 | 73.56 | 118.26 | 93.23 | Upgrade
|
| Book Value Per Share | -0.47 | -0.37 | 6.13 | 12.08 | 20.07 | 18.51 | Upgrade
|
| Tangible Book Value | -9.13 | -2.9 | 37.74 | 74.24 | 118.87 | 93.83 | Upgrade
|
| Tangible Book Value Per Share | -0.47 | -0.37 | 6.13 | 12.08 | 20.06 | 18.49 | Upgrade
|
| Machinery | - | 0.37 | 0.54 | 0.71 | 0.5 | 0.42 | Upgrade
|
| Leasehold Improvements | - | 0.21 | 0.18 | 0.18 | 0.18 | 0.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.